Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure-Reference-Cited by-同舟云学术

Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure

Published:2008-11-19 Issue:10 Volume:68 Page:1585-1590
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Dohn U M.,Boonen A,Hetland M L,Hansen M S,Knudsen L S,Hansen A,Madsen O R,Hasselquist M,Moller J M,Ostergaard M

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial;Arthritis & Rheumatology;2023-09-21

2. Serum cytokines and bone metabolic markers in patients with rheumatoid arthritis treated with biological disease modifying anti-rheumatic drugs;Clinical Rheumatology;2022-09-26

3. 11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation;International Journal of Molecular Sciences;2022-06-30

4. Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice;Frontiers in Immunology;2022-06-27

5. Impact of Treat-to-Target Therapy on Bone Mineral Density Loss in Patients With Rheumatoid Arthritis: A Prospective Cohort Study;Frontiers in Endocrinology;2022-05-17